HIV Encephalopathy Due to Drug Resistance Despite 2-Year Suppression of HIV Viremia by cART

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.54.721
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Societas Neurologica Japonica

Related search

Limited Evolution Despite Years of Measurable Viremia in a cART-treated Seronegative HIV-1 Positive Individual

2020English

Concurrent Administration of IFNα14 and cART in TKO-BLT Mice Enhances Suppression of HIV-1 Viremia but Does Not Eliminate the Latent Reservoir

Scientific Reports
Multidisciplinary
2019English

Early HIV Treatment to Forestall Drug Resistance

The Lancet Infectious Diseases
Infectious Diseases
2016English

Computational Simulations of HIV-1 ProteasessMulti-drug Resistance Due to Nonactive Site Mutation L90M

English

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon

EClinicalMedicine
Medicine
2018English

Review of HIV Antiretroviral Drug Resistance

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2008English

A Paradigm Shift to Prevent HIV Drug Resistance

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2008English

HIV-2 Treatment in Mali and Drug Resistance Antiretroviral Profile

International STD Research & Reviews
2019English

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy